Patent Commercialization Versus Product Marketing: Navigating the Distinctive Paths

Getting a patent is only half the battle. The real challenge – one that most inventors underestimate – is turning that patent into something commercially meaningful. In India, fewer than 5% of granted patents ever reach the market. That statistic alone reveals a critical gap between securing IP rights and actually generating value from them. This gap is precisely where patent commercialization and product marketing diverge – two processes that look similar on the surface but operate on entirely different logic, timelines, and relationships. Understanding those differences is essential for any inventor, law student, or IP professional navigating the patent ecosystem.

What patent commercialization actually means 🔗

Patent commercialization is the process of converting a patented invention into a commercial product or service – one that generates economic returns either for the inventor or for a party the inventor has authorized. Under the Patents Act, 1970, a patentee holds the exclusive right to make, use, sell, or distribute the patented invention in India, and may exercise that right personally or through licensees. The law, under Section 53, grants a patent a life of 20 years from the date of filing – making timely commercialization not just smart, but strategically necessary.

There are multiple routes to commercialize a patent. A patent may be commercialized either by transforming it into an end product or by transferring rights to an interested party – through licensing, outright assignment, joint ventures, or self-manufacturing. Each route involves a different level of control, risk, and resource commitment. The choice depends on what the patent holder can bring to the table: capital, technical expertise, distribution networks, and manufacturing capacity all factor in.

Product marketing: a different game entirely 🔗

Product marketing, by contrast, is the set of strategies used to promote and sell a product directly to consumers or businesses. Its orientation is outward-facing and transactional. The immediate objective is to convert interest into sales – as quickly and efficiently as possible. It involves market segmentation, positioning, branding, advertising, and distribution. The customer is always at the center: their needs, preferences, and purchasing behavior drive every decision.

When a consumer goods company launches a new detergent or a smartphone model, it uses product marketing tools – it runs campaigns, builds brand recall, and pushes for market share. The process is relatively short-cycle, and success is measured in units sold, revenue generated, and market penetration. The seller and the buyer interact within a straightforward transactional frame. The product either sells or it doesn’t.

Patent commercialization is nothing like this. It is slower, more legally dense, more relational, and far more strategically complex.

The core differences between the two 🔗

Transaction vs. partnership 🔗

The most fundamental distinction is that product marketing ends with a sale. Patent commercialization begins one. When an inventor licenses a patent to a manufacturer, that relationship extends over months or years – the licensee must develop the product, invest in production, navigate regulatory approvals, and then market it to end users. The licensor remains involved, monitoring progress and ensuring the invention is being worked as agreed. Under Section 83 of the Patents Act, 1970, there is even a legislative expectation that patents be worked on a commercial scale in India – failing which, compulsory licensing provisions under Section 84 can be triggered by third parties after three years from the grant date.

Who the “customer” is 🔗

In product marketing, the customer is the end consumer – the person who buys and uses the product. Strategy is built around their preferences, pain points, and purchasing habits. In patent commercialization, the immediate “customer” is the licensee – a company or entrepreneur with the technical capability and market access to develop the patented invention into a product. The end user of the final product may be a completely different person or entity, adding a layer of separation that product marketing simply doesn’t have to navigate.

This distinction matters enormously. A patent licensor must evaluate and persuade a sophisticated business partner – not an individual consumer. The criteria for selecting that partner are technical and legal, not demographic or psychographic. As noted by IP practitioners, due diligence in licensing requires reviewing pending infringement proceedings, projecting demand in relevant markets, and assessing the scope of patent claims – none of which has a counterpart in traditional marketing analysis.

Timelines and expectations 🔗

Product marketing campaigns often operate in weeks or quarters. A product launch, a promotional push, a seasonal campaign – these are relatively short-horizon activities. Patent commercialization is a long-term commitment. Licensing negotiations alone can take months. Once a deal is signed, the development and go-to-market phase can stretch over years. The patent holder must be prepared for this duration, structuring royalty arrangements and milestone clauses accordingly.

Protecting know-how during negotiations 🔗

One of the most delicate aspects of patent commercialization – something product marketing never has to deal with – is the challenge of disclosing enough information to attract a licensee without compromising the very know-how that makes the invention valuable. During licensing negotiations, an inventor must reveal technical details about how the invention works. But that disclosure, if unprotected, can be misused by a potential partner who walks away from negotiations and then exploits the information independently.

The standard legal tool here is the Non-Disclosure Agreement (NDA) – also called a confidentiality agreement. In India, trade secrets and know-how are protected primarily through contractual obligations regulated under the Indian Contract Act, 1872, since there is no standalone statute protecting trade secrets in India. This means the NDA is not merely a formality – it is often the primary legal safeguard available to inventors during pre-licensing conversations.

A well-drafted NDA in this context must clearly define what information is confidential, restrict its use to evaluation purposes only, and extend confidentiality obligations beyond the termination of the agreement. As the WIPO confidentiality agreement framework makes clear, signing an NDA does not imply any transfer of IP rights or grant of license – it only permits the recipient to review the confidential information for a specific purpose. Inventors should also note that owners of trade secrets can mandate licensees to extend confidentiality requirements to their own employees, subcontractors, and factory visitors.

Selecting the right licensee: more science than instinct 🔗

In product marketing, you define your target audience and direct messaging toward them. In patent commercialization, you must actively search for and evaluate potential licensees – and the selection criteria are far more rigorous. A licensor must assess a prospective licensee’s technical competence, manufacturing capacity, financial health, existing distribution networks, and experience in the relevant industry.

Choosing poorly can be costly. Research and choosing qualified licensees before finalizing any deal is essential to guarantee the patented product’s successful commercialization – a product reaches the market faster when the right partner is chosen, and that speed directly affects competitive positioning and royalty income. A licensee who lacks the resources or expertise to develop the product wastes critical years of the patent’s 20-year life.

This is particularly important for Indian universities and research institutions, which are increasingly active in generating patentable research but often lack manufacturing capabilities. Exclusive licenses are preferred in cases where the patent owner has limitations in commercializing the patent – academic bodies typically transfer technology to industry partners who have the technical and marketing expertise to bring inventions to market. The licensing agreement then becomes the bridge between laboratory and marketplace.

Building trust, not just deals 🔗

Perhaps the most underappreciated aspect of patent commercialization is its fundamentally relational character. A product marketing transaction ends when the customer pays for the product. A licensing relationship, by contrast, requires sustained trust between licensor and licensee over an extended period. The licensor depends on the licensee to faithfully develop and market the invention. The licensee depends on the licensor’s technical support and warranty that the patent is valid and enforceable.

This mutual dependence creates a dynamic that product marketing simply does not encounter. Negotiations must be approached carefully – disclosing too little makes it impossible to attract serious partners, while disclosing too much without adequate protection exposes the invention to appropriation. The relationship must be structured with clear royalty terms, development milestones, reporting obligations, and sub-licensing restrictions. In India, a licensor may lawfully restrict the use of trade secrets and know-how by the licensee or third parties, both during and after the term of the licence – a protection that reinforces this trust-based architecture.

Legal and market challenges specific to patent commercialization 🔗

Patent commercialization also faces a set of obstacles that product marketing does not. On the legal side, the validity of the patent itself may be challenged. A licensee conducting due diligence may discover pending invalidation proceedings or prior art that weakens the patent’s claims. Broad claims – which cover more of the patented technology – are generally considered more valuable and harder to circumvent, but they also attract more scrutiny. Narrow claims offer weaker protection, potentially allowing competitors to design around the patent.

On the market side, timing is everything. If you wait too long, someone else will capitalize on a similar idea and capture your niche. But if the market isn’t ready for the invention, the licensor faces an uphill battle convincing anyone to invest in development. And under India’s compulsory licensing regime, if a patent is not worked on a commercial scale in India within a reasonable time, the door opens for third parties to obtain a compulsory license from the Controller of Patents under Section 84 of the Patents Act, 1970 – a powerful reminder that commercialization is not optional, it is expected.

The Theranos example is instructive here: the company held over 2,700 patents but was ultimately declared bankrupt when its underlying technology failed to perform as claimed. Patents without genuine commercial working are, in the end, paper assets.

What this means for inventors and IP practitioners 🔗

For anyone entering the field of patent law or IP management in India, recognizing this distinction between commercialization and product marketing is foundational. Patent commercialization demands a very different skill set – one that combines legal drafting, technology assessment, business negotiation, and market strategy. It requires patience, careful disclosure management, and the ability to evaluate potential partners with the same rigour that a licensor would bring to evaluating a business acquisition.

Accurate intellectual property valuation, clear market positioning, and active protection against infringement are the three pillars that support any successful commercialization effort. Without valuation, you cannot negotiate fair royalty terms. Without positioning, you cannot identify the right licensees. And without enforcement capability, even a valid patent becomes a hollow asset.

What do you think? Given that fewer than 5% of patents in India are successfully commercialized, what structural changes – in how inventors are educated, or how licensing ecosystems are supported – could meaningfully improve that number? And when it comes to protecting know-how during licensing negotiations, do you think India’s current reliance on contract law and NDAs – without a dedicated trade secrets statute – provides adequate protection for inventors?

References

1. https://www.mondaq.com/india/patent/849260/commercializing-patents-methods-and-challenges
2. https://indiankanoon.org/doc/1937976/
3. https://www.lexology.com/library/detail.aspx?g=761701fb-a65e-4717-88fc-b8d0b5f8552f
4. https://www.iiprd.com/commentary-on-compulsory-licensing-under-the-patents-act-1970/
5. https://ssrana.in/articles/patent-licensing-strategies-effective-ip-commercialization/
6. https://practiceguides.chambers.com/practice-guides/trade-secrets-2025/india
7. https://www.wipo.int/en/web/traditional-knowledge/databases/contracts/texts/2023-11-0010
8. https://nanoschool.in/ip2/
9. https://www.lexology.com/library/detail.aspx?g=5ed6a7c9-a712-490d-8647-723a76722cf1
10. https://patentpc.com/blog/top-patent-commercialization-strategies-for-inventors